I'm telling you guys - the job title they have posted is the exact title that Progenics used for Tracey's job and she was in charge of maintaining the TMF for the clinical trials. They wouldn't need someone for that unless they will have a TMF they are bringing back in house.
I agree. We have adults in charge now, which includes keeping quiet until they achieve a catalyst or are required to report. I don’t buy into the partnership/buyout fantasies. I have gone through enough senior management turnovers to know there will be an internal process of realignment. The new CEO will need to sort through the data to prioritize resources (staff and financial). We are in for an extended quiet period.